Successful Pregnancy and Delivery at Term Following Intravenous Immunoglobulin Therapy with Heparin for Unexplained Recurrent Pregnancy Loss Suspected of Immunological Abnormalities: A Case Report and Brief Literature Review
Abstract
:1. Introduction
2. Case Presentation
3. Discussion
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
COH | controlled ovarian hyperstimulation |
IVIG | intravenous immunoglobulin |
LDA | low-dose aspirin |
RPL | recurrent pregnancy loss |
Th1 | helper 1 T cell |
Th2 | helper 2 T cell |
UFH | unfractionated heparin |
uRPL | unexplained recurrent pregnancy loss |
References
- ESHRE Guideline Group on RPL; Bender Atik, R.; Christiansen, O.B.; Elson, J.; Kolte, A.M.; Lewis, S.; Middeldorp, S.; Nelen, W.; Peramo, B.; Quenby, S.; et al. ESHRE Guideline: Recurrent Pregnancy Loss. Hum. Reprod. Open 2018, 2018, hoy004. [Google Scholar] [CrossRef] [PubMed]
- Khalife, D.; Ghazeeri, G.; Kutteh, W. Review of Current Guidelines for Recurrent Pregnancy Loss: New Strategies for Optimal Evaluation of Women Who May Be Superfertile. Semin. Perinatol. 2019, 43, 105–115. [Google Scholar] [CrossRef] [PubMed]
- Practice Committee of the American Society for Reproductive Medicine. Evaluation and Treatment of Recurrent Pregnancy Loss: A Committee Opinion. Fertil. Steril. 2012, 98, 1103–1111. [Google Scholar] [CrossRef]
- Sugiura-Ogasawara, M.; Ozaki, Y.; Suzumori, N. Management of Recurrent Miscarriage. J. Obstet. Gynaecol. Res. 2014, 40, 1174–1179. [Google Scholar] [CrossRef] [PubMed]
- Saito, S.; Nakashima, A.; Shima, T. Future Directions of Studies for Recurrent Miscarriage Associated with Immune Etiologies. J. Reprod. Immunol. 2011, 90, 91–95. [Google Scholar] [CrossRef]
- Wang, W.; Sung, N.; Gilman-Sachs, A.; Kwak-Kim, J. T Helper (Th) Cell Profiles in Pregnancy and Recurrent Pregnancy Losses: Th1/Th2/Th9/Th17/Th22/Tfh Cells. Front. Immunol. 2020, 11, 2025. [Google Scholar] [CrossRef]
- Chen, P.; Zhou, L.; Chen, J.; Lu, Y.; Cao, C.; Lv, S.; Wei, Z.; Wang, L.; Chen, J.; Hu, X.; et al. The Immune Atlas of Human Deciduas With Unexplained Recurrent Pregnancy Loss. Front. Immunol. 2021, 12, 689019. [Google Scholar] [CrossRef]
- Coulam, C.B.; Acacio, B. Does Immunotherapy for Treatment of Reproductive Failure Enhance Live Births? Am. J. Reprod. Immunol. 2012, 67, 296–304. [Google Scholar] [CrossRef]
- Maddur, M.S.; Kaveri, S.V.; Bayry, J. Circulating Normal IgG as Stimulator of Regulatory T Cells: Lessons from Intravenous Immunoglobulin. Trends Immunol. 2017, 38, 789–792. [Google Scholar] [CrossRef]
- Coulam, C.B. Intralipid Treatment for Women with Reproductive Failures. Am. J. Reprod. Immunol. 2021, 85, e13290. [Google Scholar] [CrossRef] [PubMed]
- Galeotti, C.; Kaveri, S.V.; Bayry, J. IVIG-Mediated Effector Functions in Autoimmune and Inflammatory Diseases. Int. Immunol. 2017, 29, 491–498. [Google Scholar] [CrossRef]
- Ahmadi, M.; Ghaebi, M.; Abdolmohammadi-Vahid, S.; Abbaspour-Aghdam, S.; Hamdi, K.; Abdollahi-Fard, S.; Danaii, S.; Mosapour, P.; Koushaeian, L.; Dolati, S.; et al. NK Cell Frequency and Cytotoxicity in Correlation to Pregnancy Outcome and Response to IVIG Therapy among Women with Recurrent Pregnancy Loss. J. Cell. Physiol. 2019, 234, 9428–9437. [Google Scholar] [CrossRef] [PubMed]
- Lee, S.K.; Kim, J.Y.; Han, A.R.; Hur, S.E.; Kim, C.J.; Kim, T.H.; Cho, B.R.; Han, J.W.; Han, S.G.; Na, B.J.; et al. Intravenous Immunoglobulin G Improves Pregnancy Outcome in Women with Recurrent Pregnancy Losses with Cellular Immune Abnormalities. Am. J. Reprod. Immunol. 2016, 75, 59–68. [Google Scholar] [CrossRef] [PubMed]
- Wong, L.F.; Porter, T.F.; Scott, J.R. Immunotherapy for Recurrent Miscarriage. Cochrane Database Syst. Rev. 2014, 2014, CD000112. [Google Scholar] [CrossRef]
- Christiansen, O.B.; Kolte, A.M.; Krog, M.C.; Nielsen, H.S.; Egerup, P. Treatment with Intravenous Immunoglobulin in Patients with Recurrent Pregnancy Loss: An Update. J. Reprod. Immunol. 2019, 133, 37–42. [Google Scholar] [CrossRef]
- Stephenson, M.D.; Kutteh, W.H.; Purkiss, S.; Librach, C.; Schultz, P.; Houlihan, E.; Liao, C. Intravenous Immunoglobulin and Idiopathic Secondary Recurrent Miscarriage: A Multicentered Randomized Placebo-Controlled Trial. Hum. Reprod. 2010, 25, 2203–2209. [Google Scholar] [CrossRef]
- Perino, A.; Vassiliadis, A.; Vucetich, A.; Colacurci, N.; Menato, G.; Cignitti, M.; Semprini, A.E. Short-Term Therapy for Recurrent Abortion Using Intravenous Immunoglobulins: Results of a Double-Blind Placebo-Controlled Italian Study. Hum. Reprod. 1997, 12, 2388–2392. [Google Scholar] [CrossRef]
- Christiansen, O.B.; Larsen, E.C.; Egerup, P.; Lunoee, L.; Egestad, L.; Nielsen, H.S. Intravenous Immunoglobulin Treatment for Secondary Recurrent Miscarriage: A Randomised, Double-Blind, Placebo-Controlled Trial. BJOG Int. J. Obstet. Gynaecol. 2015, 122, 500–508. [Google Scholar] [CrossRef]
- Yamada, H.; Deguchi, M.; Saito, S.; Takeshita, T.; Mitsui, M.; Saito, T.; Nagamatsu, T.; Takakuwa, K.; Nakatsuka, M.; Yoneda, S.; et al. Intravenous Immunoglobulin Treatment in Women with Four or More Recurrent Pregnancy Losses: A Double-Blind, Randomised, Placebo-Controlled Trial. EClinicalMedicine 2022, 50, 101527. [Google Scholar] [CrossRef] [PubMed]
- Christiansen, O.B.; Pedersen, B.; Rosgaard, A.; Husth, M. A Randomized, Double-Blind, Placebo-Controlled Trial of Intravenous Immunoglobulin in the Prevention of Recurrent Miscarriage: Evidence for a Therapeutic Effect in Women with Secondary Recurrent Miscarriage. Hum. Reprod. 2002, 17, 809–816. [Google Scholar] [CrossRef] [Green Version]
- Yamada, H.; Takeda, M.; Maezawa, Y.; Ebina, Y.; Hazama, R.; Tanimura, K.; Wakui, Y.; Shimada, S. A High Dose Intravenous Immunoglobulin Therapy for Women with Four or More Recurrent Spontaneous Abortions. ISRN Obstet. Gynecol. 2012, 2012, 512732. [Google Scholar] [CrossRef]
- Saab, W.; Seshadri, S.; Huang, C.; Alsubki, L.; Sung, N.; Kwak-Kim, J. A Systemic Review of Intravenous Immunoglobulin G Treatment in Women with Recurrent Implantation Failures and Recurrent Pregnancy Losses. Am. J. Reprod. Immunol. 2021, 85, e13395. [Google Scholar] [CrossRef]
- Pasquier, E.; de Saint Martin, L.; Bohec, C.; Chauleur, C.; Bretelle, F.; Marhic, G.; Le Gal, G.; Debarge, V.; Lecomte, F.; Denoual-Ziad, C.; et al. Enoxaparin for Prevention of Unexplained Recurrent Miscarriage: A Multicenter Randomized Double-Blind Placebo-Controlled Trial. Blood 2015, 125, 2200–2205. [Google Scholar] [CrossRef] [PubMed]
- Schleussner, E.; Kamin, G.; Seliger, G.; Rogenhofer, N.; Ebner, S.; Toth, B.; Schenk, M.; Henes, M.; Bohlmann, M.K.; Fischer, T.; et al. Low-Molecular-Weight Heparin for Women with Unexplained Recurrent Pregnancy Loss: A Multicenter Trial with a Minimization Randomization Scheme. Ann. Intern. Med. 2015, 162, 601–609. [Google Scholar] [CrossRef] [PubMed]
- Liu, X.; Qiu, Y.; Yu, E.D.; Xiang, S.; Meng, R.; Niu, K.F.; Zhu, H. Comparison of Therapeutic Interventions for Recurrent Pregnancy Loss in Association with Antiphospholipid Syndrome: A Systematic Review and Network Meta-Analysis. Am. J. Reprod. Immunol. 2020, 83, e13219. [Google Scholar] [CrossRef]
- Perez, E.E.; Orange, J.S.; Bonilla, F.; Chinen, J.; Chinn, I.K.; Dorsey, M.; El-Gamal, Y.; Harville, T.O.; Hossny, E.; Mazer, B.; et al. Update on the Use of Immunoglobulin in Human Disease: A Review of Evidence. J. Allergy Clin. Immunol. 2017, 139, S1–S46. [Google Scholar] [CrossRef]
- Kwak-Kim, J.Y.H.; Chung-Bang, H.S.; Ng, S.C.; Ntrivalas, E.I.; Mangubat, C.P.; Beaman, K.D.; Beer, A.E.; Gilman-Sachs, A. Increased T Helper 1 Cytokine Responses by Circulating T Cells Are Present in Women with Recurrent Pregnancy Losses and in Infertile Women with Multiple Implantation Failures after IVF. Hum. Reprod. 2003, 18, 767–773. [Google Scholar] [CrossRef]
- Lee, S.K.; Na, B.J.; Kim, J.Y.; Hur, S.E.; Lee, M.; Gilman-Sachs, A.; Kwak-Kim, J. Determination of Clinical Cellular Immune Markers in Women with Recurrent Pregnancy Loss. Am. J. Reprod. Immunol. 2013, 70, 398–411. [Google Scholar] [CrossRef]
- Ahmadi, M.; Abdolmohammadi-Vahid, S.; Ghaebi, M.; Aghebati-Maleki, L.; Afkham, A.; Danaii, S.; Abdollahi-Fard, S.; Heidari, L.; Jadidi-Niaragh, F.; Younesi, V. Effect of Intravenous immunoglobulin on Th1 and Th2 lymphocytes and improvement of pregnancy outcome in recurrent pregnancy loss (RPL). Biomed. Pharmacother. 2017, 92, 1095–1102. [Google Scholar] [CrossRef] [PubMed]
- Marron, K.; Harrity, C. Correlation of peripheral blood and endometrial immunophenotyping in ART: Is peripheral blood sampling useful? J. Assist. Reprod. Genet. 2022. [Google Scholar] [CrossRef] [PubMed]
- Feyaerts, D.; Benner, M.; van Cranenbroek, B.; van der Heijden, O.W.H.; Joosten, I.; van der Molen, R.G. Human uterine lymphocytes acquire a more experienced and tolerogenic phenotype during pregnancy. Sci. Rep. 2017, 7, 2884. [Google Scholar] [CrossRef] [PubMed]
- Hosseini, S.; Shokri, F.; Pour, S.A.; Jeddi-Tehrani, M.; Nikoo, S.; Yousefi, M.; Zarnani, A.-H. A shift in the balance of T17 and Treg cells in menstrual blood of women with unexplained recurrent spontaneous abortion. J. Reprod. Immunol. 2016, 116, 13–22. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Mitsui, J.; Ota, K.; Takayanagi, Y.; Nako, Y.; Tajima, M.; Fukui, A.; Kawai, K. Successful Pregnancy and Delivery at Term Following Intravenous Immunoglobulin Therapy with Heparin for Unexplained Recurrent Pregnancy Loss Suspected of Immunological Abnormalities: A Case Report and Brief Literature Review. J. Clin. Med. 2023, 12, 1250. https://doi.org/10.3390/jcm12041250
Mitsui J, Ota K, Takayanagi Y, Nako Y, Tajima M, Fukui A, Kawai K. Successful Pregnancy and Delivery at Term Following Intravenous Immunoglobulin Therapy with Heparin for Unexplained Recurrent Pregnancy Loss Suspected of Immunological Abnormalities: A Case Report and Brief Literature Review. Journal of Clinical Medicine. 2023; 12(4):1250. https://doi.org/10.3390/jcm12041250
Chicago/Turabian StyleMitsui, Junichiro, Kuniaki Ota, Yuko Takayanagi, Yurie Nako, Makiko Tajima, Atsushi Fukui, and Kiyotaka Kawai. 2023. "Successful Pregnancy and Delivery at Term Following Intravenous Immunoglobulin Therapy with Heparin for Unexplained Recurrent Pregnancy Loss Suspected of Immunological Abnormalities: A Case Report and Brief Literature Review" Journal of Clinical Medicine 12, no. 4: 1250. https://doi.org/10.3390/jcm12041250